EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome

Silvia Actis, Massimiliano Cazzaniga, Marta D’Alonzo, Gaetano Perrini, Margherita Giorgi, Luca Pace, Maria Pascotto, Beatrice Campigotto, Annamaria Ferrero, Valentina Elisabetta Bounous

Current Oncology · 17.11.2026 · 33 (11) · 710

DOI: 10.3390/curroncol33110710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 17.11.2026. Verfasst von Silvia Actis und 9 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lynch syndrome is the most common hereditary syndrome predisposing to endometrial cancer, but the mechanisms contributing to tumor development remain incompletely understood. This review aimed to summarise current evidence on the composition and potential pathogenic role of the microbiota in Lynch syndrome-associated endometrial cancer and to explore its clinical implications. A systematic literature search of PubMed/MEDLINE and Embase was conducted between October and November 2025 using predefined terms related to microbiota, carcinogenesis, endometrial cancer, and Lynch syndrome. Available evidence suggests that alterations in the microbiota may contribute to carcinogenesis through chronic inflammation, immune modulation, metabolic changes, and bacterial genotoxicity. Studies in Lynch syndrome carriers with endometrial or colorectal cancer report an increased abundance of potentially pro-inflammatory Gram-negative bacteria, including Bacteroides fragilis and Fusobacterium nucleatum, together with a reduction in short-chain fatty acid-producing bacteria such as Faecalibacterium, Blautia, and Butyrivibrio. Microbial metabolites, including butyrate, may have protective effects, whereas bacterial β-glucuronidase activity may increase estrogen bioavailability and contribute to a tumor-promoting environment. Emerging evidence also suggests that the microbiota may influence treatment response and toxicity. Overall, current evidence supports a potential role for the microbiota in Lynch syndrome-associated endometrial carcinogenesis, although data remain limited. Further studies are needed to determine whether microbiota profiling could contribute to risk stratification, prevention, and personalized therapeutic strategies.

Zitieren

APA

Actis, S., Cazzaniga, M., D’Alonzo, M., Perrini, G., Giorgi, M., Pace, L., Pascotto, M., Campigotto, B., Ferrero, A., & Bounous, V. E. (2026). Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome. Current Oncology, 33(11), 710. https://doi.org/10.3390/curroncol33110710

Vancouver

Actis S, Cazzaniga M, D’Alonzo M, Perrini G, Giorgi M, Pace L, et al. Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome. Current Oncology. 2026;33(11):710. doi:10.3390/curroncol33110710

BibTeX
@article{Actis2026,
  author = {Actis, Silvia and Cazzaniga, Massimiliano and D’Alonzo, Marta and Perrini, Gaetano and Giorgi, Margherita and Pace, Luca and Pascotto, Maria and Campigotto, Beatrice and Ferrero, Annamaria and Bounous, Valentina Elisabetta},
  title = {Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {11},
  pages = {710},
  doi = {10.3390/curroncol33110710}
}
Kostenlos starten →